Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v2-FR | Version v2-FR | |
|---|---|---|
| Language | French | French |
| Date Updated | 2025-12-22 | 2025-12-22 |
| Drug Identification Number | 02439379 | 02439379 |
| Brand name | ROPIVACAINE HYDROCHLORIDE INJECTION, USP | ROPIVACAINE HYDROCHLORIDE INJECTION, USP |
| Common or Proper name | ROPIVACAINE HYDROCHLORIDE INJECTION, USP | ROPIVACAINE HYDROCHLORIDE INJECTION, USP |
| Company Name | FRESENIUS KABI CANADA LTD | FRESENIUS KABI CANADA LTD |
| Ingredients | ROPIVACAINE HYDROCHLORIDE | ROPIVACAINE HYDROCHLORIDE |
| Strength(s) | 2MG | 2MG |
| Dosage form(s) | SOLUTION | SOLUTION |
| Route of administration | EPIDURAL INFILTRATION INFILTRATION EPIDURAL | EPIDURAL INFILTRATION INFILTRATION EPIDURAL |
| Packaging size | 100mL | 100mL |
| ATC code | N01BB | N01BB |
| ATC description | ANESTHETICS, LOCAL | ANESTHETICS, LOCAL |
| Reason for shortage | Other (Please describe in comments) | Other (Please describe in comments) |
| Anticipated start date | ||
| Actual start date | 2026-01-01 | 2026-01-01 |
| Estimated end date | 2026-02-01 | 2026-02-01 |
| Actual end date | ||
| Shortage status | Anticipated shortage | Anticipated shortage |
| Tier 3 Status | No | No |
| Company comments | Due to unforeseen circumstances, our Ropivacaine Hydrochloride Injection, USP 2 mg/mL, 200 mL Bags, will be on reduced allocations starting January 1, 2026 at 50% of historical monthly demand. We are working diligently with our plant to improve the supply situation. | Due to unforeseen circumstances, our Ropivacaine Hydrochloride Injection, USP 2 mg/mL, 200 mL Bags, will be on reduced allocations starting January 1, 2026 at 50% of historical monthly demand. We are working diligently with our plant to improve the supply situation. |
| Health Canada comments |